# Ex Vivo Plasma Application on Human Brain Microvascular Endothelial-like Cells for Blood–Brain Barrier Modeling

**Authors:** Sophie-Charlotte Nelz, Elisabeth Lück, Anne Schölzel, Martin Sauer, Jacqueline Heskamp, Sandra Doss

PMC · DOI: 10.3390/ijms26073334 · 2025-04-03

## TL;DR

This study shows that heparin-anticoagulated plasma supports the function of brain endothelial-like cells, improving in vitro blood-brain barrier models for research.

## Contribution

The study demonstrates that heparin-anticoagulated plasma enhances the barrier function of hiPSC-derived endothelial-like cells without affecting viability.

## Key findings

- Heparin-anticoagulated plasma did not significantly alter cell viability parameters compared to medium.
- Heparin plasmas improved barrier function and induced a von Willebrand factor signal in endothelial-like cells.
- Continuous TEER measurements confirmed the positive impact of sodium-heparin plasma on barrier function in a triple-culture model.

## Abstract

hiPSC-derived blood–brain barrier (BBB) models are valuable for pharmacological and physiological studies, yet their translational potential is limited due to insufficient cell phenotypes and the neglection of the complex environment of the BBB. This study evaluates the plasma compatibility with hiPSC-derived microvascular endothelial-like cells to enhance the translational potential of in vitro BBB models. Therefore, plasma samples (sodium/lithium heparin, citrate, EDTA) and serum from healthy donors were tested on hiPSC-derived microvascular endothelial-like cells at concentrations of 100%, 75%, and 50%. After 24 h, cell viability parameters were assessed. The impact of heparin-anticoagulated plasmas was further evaluated regarding barrier function and endothelial phenotype of differentiated endothelial-like cells. Finally, sodium-heparin plasma was tested in an isogenic triple-culture BBB model with continuous TEER measurements for 72 h. Only the application of heparin-anticoagulated plasmas did not significantly alter viability parameters compared to medium. Furthermore, heparin plasmas improved barrier function without increasing cell density and induced a von Willebrand factor signal. Finally, continuous TEER measurements of the triple-culture model confirmed the positive impact of sodium-heparin plasma on barrier function. Consequently, heparin-anticoagulated plasmas were proven to be compatible with hiPSC-derived microvascular endothelial-like cells. Thereby, the translational potential of BBB models can be substantially improved in the future.

## Linked entities

- **Chemicals:** citrate (PubChem CID 31348), EDTA (PubChem CID 6049)

## Full-text entities

- **Genes:** VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}
- **Chemicals:** sodium/lithium heparin (-), citrate (MESH:D019343), EDTA (MESH:D004492), heparin (MESH:D006493)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11989380/full.md

---
Source: https://tomesphere.com/paper/PMC11989380